Instacart confidentially filed for an initial public offering with the Securities and Exchange earlier this year.
Mati Gil, CEO of AION Labs, describes how its new startup OMEC.AI came to fruition and what it aims to accomplish for drug discovery and development.
Device Connect for Fitbit aims to help healthcare and life science organizations use and analyze data from Fitbit's health-tracking wearables.
The company’s device, Primary Relief, is the latest of DyAnsys’ long list of devices to receive FDA clearance.
The JMIR study found themes like cost, functionality, progress tracking and educational content were important to consumers.
The company’s Seer Home device allows for potential epilepsy diagnosis through at-home data collection.
